Five years ago, Milton Rubin created the Milton B. Rubin Family Endowed Chair as a means of expressing his gratitude for the ...

What's new in proton therapy? Read the latest news and views from Fred Hutch's proton therapy facility’s patients and ...

Katie Monin, a Seattle lawyer and mother of two young children, chose proton therapy as part of her treatment for brain ...

Join our first-ever Fred Hutch Giving Day September 17, 2025 as we celebrate 50 years of breakthroughs — in cancer, infectious disease and fundamental research.

It’s a very different world now in cancer,” said longtime patient advocate Ginny Mason. “Now you need to understand the ...

Dr. Rainer Storb began studying bone marrow transplantation when the field was in its infancy. As he retires 60 years later, ...

Researchers at Fred Hutch Cancer Center invented a new screening method called ReLiC that uses CRISPR-Cas9 to test all the ...

A study published in Nature shows that certain autoantibodies may influence how cancer patients respond to immunotherapy. Autoantibodies are proteins produced by the immune system and have typically ...

Going back to school is different for children with cancer Many children look forward to returning to school in the fall, even if it’s only to see their friends. Others might suffer from anxiety. But ...

Fred Hutch Cancer Center is leading the newly launched Vanguard Study, a national study of a new type of blood test that screens for several different cancers called multi-cancer detection (MCD) tests ...

Eight researchers specializing in adult oncology from Fred Hutch Cancer Center and the University of Washington have been awarded a total of $7,268,202 from the Kuni Foundation’s Discovery Grant ...

Fred Hutch announces eight recipients of the 2025 Dr. Eddie Méndez Scholar Award, which honors exceptional postdoctoral researchers in the areas of cancer, infectious disease and basic science.